Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This protocol describes a randomized, double-arm, parallel-group, open-label controlled study
that aims to evaluate the efficacy of Chinese herbal medicine on head and neck cancer
patients with oral mucositis toxicities and quality of life during radiotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborator:
National Research Institute of Chinese Medicine, Ministry of Health and Welfare